title: Ten years of breast screening in the Nova Scotia Breast Screening Program, 1991-2001. experience: use of an adaptable stereotactic device in the diagnosis of screening-detected abnormalities.
abstract: OBJECTIVE
  To evaluate and present 10-year outcomes of the Nova Scotia Breast Screening Program (NSBSP), a population-based screening program in the province of Nova Scotia, Canada, total population 900 000.
  
  
  METHODS
  Organized Breast Screening Program in Nova Scotia, Canada.
  
  
  METHODS
  Rates of participation, abnormal referrals, cancer detection rates, and benign:malignant (B:M) rates for core biopsy and surgical biopsy were calculated for asymptomatic women receiving a mammogram through the NSBSP 1991-2001.
  
  
  RESULTS
  Of 192 454 mammograms performed on 71 317 women, 33% were aged 40 to 49 years, 39% aged 50 to 59 years, 23% aged 60 to 69 years, and 5% aged 70 years and over. Cancer detection rate increased in each age group respectively: 3.7, 5.8, 9.7, and 13.5 per 1000 population on first-time screens. The positive predictive value of an abnormal screen increased with increasing age groups. Benign breast surgery decreased with increased use of needle core breast biopsy (NCBB). Open surgery decreased from 25 to 6 surgeries per 1000 screens. Of 1519 open surgical procedures (1328 women), 878 cancers were removed, with 37% 10 mm or less, and 61% 15 mm or less. In 613 women in whom the node status was assessed, 79% were negative.
  
  
  CONCLUSIONS
  A quality screening program incorporating NCBB in the diagnostic work-up is effective in the early detection of breast cancer and results in less open surgery, particularly in younger women.
authors.affiliation: Department of Radiology, Queen Elizabeth II Health Sciences Centre, and Faculty of Medicine, Dalhousie University, Nova Scotia Breast Screening Program, Halifax, NS. judy.caines@cdha.nshealth.ca
authors.forename: Judy S
authors.initials: JS
authors.lastname: Caines
authors.forename: Gerald H
authors.initials: GH
authors.lastname: Schaller
authors.forename: Sian E
authors.initials: SE
authors.lastname: Iles
authors.forename: Eric R
authors.initials: ER
authors.lastname: Woods
authors.forename: Penny J
authors.initials: PJ
authors.lastname: Barnes
authors.forename: Alphonse J
authors.initials: AJ
authors.lastname: Johnson
authors.forename: Gordon R M
authors.initials: GR
authors.lastname: Jones
authors.forename: Joy N
authors.initials: JN
authors.lastname: Borgaonkar
authors.forename: Judy A
authors.initials: JA
authors.lastname: Rowe
authors.forename: Trevor J
authors.initials: TJ
authors.lastname: Topp
authors.forename: Geoffrey A
authors.initials: GA
authors.lastname: Porter
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001706:Biopsy; D001940:Breast / Q000473:pathology*; D001943:Breast Neoplasms / Q000175:diagnosis*; D005260:Female; D006801:Humans; D008327:Mammography / Q000706:statistics & numerical data*; D008403:Mass Screening / Q000706:statistics & numerical data*; D008875:Middle Aged; D009674:Nova Scotia; D015397:Program Evaluation; D013997:Time Factors